PECAM1 and thyroid gland carcinoma: IHC with Ki67 and CD31 antibodies suggested that the in vivo proliferation and MVD of thyroid carcinoma were increased in CBS group compared with the Mock group and decreased in the sh-CBS group compared with the sh-Scb group.